BioCorRx (BICX) Treasury Shares (2013 - 2026)

BioCorRx (BICX) has 14 years of Treasury Shares data on file, last reported at $4.8 million in Q1 2026.

• Quarterly Treasury Shares rose 156.77% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 million (up 156.77% YoY) and the FY2025 annual result came in at $5.1 million, up 379.35% from the prior year.
• Treasury Shares fell to $4.8 million in Q1 2026 per BICX's latest filing, from $5.1 million in the prior quarter.
• The five-year high for Treasury Shares was $5.1 million in Q4 2025, with the low at $54474.0 in Q3 2023.
• Average Treasury Shares over 5 years is $1.3 million, with a median of $676447.0 recorded in 2023.
• Year-over-year, Treasury Shares slumped 86.27% in 2022 and soared 1026.27% in 2023.
• BioCorRx's Treasury Shares stood at $444167.0 in 2022, then jumped by 297.57% to $1.8 million in 2023, then tumbled by 39.35% to $1.1 million in 2024, then surged by 379.35% to $5.1 million in 2025, then slipped by 6.67% to $4.8 million in 2026.
• Business Quant data shows BICX's Treasury Shares at $4.8 million in Q1 2026, $5.1 million in Q4 2025, and $1.2 million in Q3 2025.